Artificial Int: Neurogenic Bowel Education in Spinal Cord Injury Patients (ArtInt)

Senem Duman

Status: Begins enrollment this month

Conditions: Neurogenic Bowel Dysfunction; Spinal Cord Injury

Treatments: Other: Mobil Application

Study type: Interventional

Funder types: Other

Identifiers

NCT07369349

SaglikBilimleriU-1

Ethics Committee (Other Identifier)

Details and patient eligibility

About

The aim of this study is to evaluate the effectiveness of patient education delivered through an artificial intelligence (AI)-based mobile application in the management of neurogenic bowel dysfunction in individuals with spinal cord injury. Within the scope of the study, it will be examined whether the mobile application reduces neurogenic bowel scores, contributes to maintaining stool scores within the normal range, and improves the quality of life of individuals. Accordingly, the AI-based education model to be developed is expected to facilitate the integration of bowel management practices into daily life, prevent complications, and enhance social participation.

-

Enrollment: 34 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Volunteers who consent to participate.
• Age over 18 years.
• Diagnosed with spinal cord injury (SCI).
• Diagnosed with neurogenic bowel dysfunction (NBD).
• Not in spinal shock (return of the bulbocavernosus reflex).
• Having received routine NBD education at the study center within the last month.

Exclusion criteria

• Individuals with mental retardation.
• Individuals with visual and/or hearing impairments.
• Individuals with communication problems.
• Individuals with a history of additional injuries other than SCI (e.g., head trauma, pelvic injury, pelvic surgery).
• Individuals diagnosed with neurological disorders such as stroke, Parkinson's disease, polyneuropathy, or multiple sclerosis.
• Individuals with irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD).
• Individuals diagnosed with gastrointestinal malignancy.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

34 participants in 2 patient groups

Control Group

No Intervention group

Description:

The control group consisted of participants who only received the hospital's routine NBD education. No additional intervention was provided. The NBD education was delivered by clinical nurses. At the end of the 4th and 12th weeks, the links for the post-tests were sent to the participants in the control group via WhatsApp messages to their phones. After the completion of the study, a link to the mobile application was also provided to the control group via WhatsApp along with an explanatory note.

intervention group

Experimental group

Description:

İndividuals in the intervention group will receive the same routine education as the control group. In addition to the routine education, on the day of discharge, a link will be sent to their phones through which the mobile application will be downloaded. Participants will create an account in the mobile application by entering their name, surname, and password. The purpose of installing the mobile application on the day of discharge is to prevent individuals in the control group from becoming aware of the mobile application. After discharge, participants will be followed up during the 4th and 12th weeks.

Treatment:

Other: Mobil Application